Loading…
Examining the Chirality, Conformation and Selective Kinase Inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)
Here, we examine the significance that stereochemistry plays within the clinically relevant Janus kinase 3 (Jak3) inhibitor 1 (CP-690,550). A synthesis of all four enantiopure stereoisomers of the drug was carried out and an examination of each compound revealed that only the enantiopure 3R,4R isome...
Saved in:
Published in: | Journal of medicinal chemistry 2008-12, Vol.51 (24), p.8012-8018 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-a537t-31b5970c24059b3a967bb6ec396c48cd914bfb1553ac95c5f1ae3afacfbd3aac3 |
---|---|
cites | cdi_FETCH-LOGICAL-a537t-31b5970c24059b3a967bb6ec396c48cd914bfb1553ac95c5f1ae3afacfbd3aac3 |
container_end_page | 8018 |
container_issue | 24 |
container_start_page | 8012 |
container_title | Journal of medicinal chemistry |
container_volume | 51 |
creator | Jiang, Jian-kang Ghoreschi, Kamran Deflorian, Francesca Chen, Zhi Perreira, Melissa Pesu, Marko Smith, Jeremy Nguyen, Dac-Trung Liu, Eric H Leister, William Costanzi, Stefano O’Shea, John J Thomas, Craig J |
description | Here, we examine the significance that stereochemistry plays within the clinically relevant Janus kinase 3 (Jak3) inhibitor 1 (CP-690,550). A synthesis of all four enantiopure stereoisomers of the drug was carried out and an examination of each compound revealed that only the enantiopure 3R,4R isomer was capable of blocking Stat5 phosphorylation (Jak3 dependent). Each compound was profiled across a panel of over 350 kinases, which revealed a high level of selectivity for the Jak family kinases for these related compounds. Each stereoisomer retained a degree of binding to Jak3 and Jak2 and the 3R,4S and 3S,4R stereoisomers were further revealed to have binding affinity for selected members of the STE7 and STE20 subfamily of kinases. Finally, an appraisal of the minimum energy conformation of each stereoisomer and molecular docking at Jak3 was performed in an effort to better understand each compounds selectivity and potency profiles. |
doi_str_mv | 10.1021/jm801142b |
format | article |
fullrecord | <record><control><sourceid>acs_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2660606</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>f70934955</sourcerecordid><originalsourceid>FETCH-LOGICAL-a537t-31b5970c24059b3a967bb6ec396c48cd914bfb1553ac95c5f1ae3afacfbd3aac3</originalsourceid><addsrcrecordid>eNptkc1u1DAQxyMEokvhwAugXJA20hr8mWwulVBUaEUr2m05IWRNHKfxktiRk1abh-Pd8HZXW5CQD_bM_Obv-YiitwR_IJiSj-tuiQnhtHwWzYigGPEl5s-jGcaUIppSdhS9GoY1xpgRyl5GRyTHgmUinUW_TzfQGWvsXTw2Oi4a46E147SIC2dr5zsYjbMx2Cq-0a1Wo3nQ8VdjYdDxuW1MaR7jro4Zms_ZasFXCeKo02MztSj4dq95dob6yXvXuh90wVD1M1imM5WxgZ7aZFuES3rTa__oJFtnyHcb13vXg9XWjN60Op4XVyjN8UIInLyOXtTQDvrN_j6Ovn8-vS3O0MW3L-fFpwsEoc0RMVKKPMOKcizykkGeZmWZasXyVPGlqnLCy7okQjBQuVCiJqAZ1KDqsmIAih1HJzvd_r7sdKW0HcOYZB9aAD9JB0b-G7GmkXfuQdI0xeEEgWQnoLwbBq_rQy7BcrtDedhhYN_9_dkTuV9aAN7vARgUtLUHq8xw4CjOl4JyHji048ww6s0hDv6XTLOgJG-vbuRKXF4X_PJaZk-6oAa5dvfehpn-p8A_qYnAKg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Examining the Chirality, Conformation and Selective Kinase Inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)</source><creator>Jiang, Jian-kang ; Ghoreschi, Kamran ; Deflorian, Francesca ; Chen, Zhi ; Perreira, Melissa ; Pesu, Marko ; Smith, Jeremy ; Nguyen, Dac-Trung ; Liu, Eric H ; Leister, William ; Costanzi, Stefano ; O’Shea, John J ; Thomas, Craig J</creator><creatorcontrib>Jiang, Jian-kang ; Ghoreschi, Kamran ; Deflorian, Francesca ; Chen, Zhi ; Perreira, Melissa ; Pesu, Marko ; Smith, Jeremy ; Nguyen, Dac-Trung ; Liu, Eric H ; Leister, William ; Costanzi, Stefano ; O’Shea, John J ; Thomas, Craig J</creatorcontrib><description>Here, we examine the significance that stereochemistry plays within the clinically relevant Janus kinase 3 (Jak3) inhibitor 1 (CP-690,550). A synthesis of all four enantiopure stereoisomers of the drug was carried out and an examination of each compound revealed that only the enantiopure 3R,4R isomer was capable of blocking Stat5 phosphorylation (Jak3 dependent). Each compound was profiled across a panel of over 350 kinases, which revealed a high level of selectivity for the Jak family kinases for these related compounds. Each stereoisomer retained a degree of binding to Jak3 and Jak2 and the 3R,4S and 3S,4R stereoisomers were further revealed to have binding affinity for selected members of the STE7 and STE20 subfamily of kinases. Finally, an appraisal of the minimum energy conformation of each stereoisomer and molecular docking at Jak3 was performed in an effort to better understand each compounds selectivity and potency profiles.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm801142b</identifier><identifier>PMID: 19053756</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Columbus, OH: American Chemical Society</publisher><subject>Biological and medical sciences ; Chemistry, Pharmaceutical - methods ; Drug Design ; Humans ; Hydrogen Bonding ; Immunomodulators ; Inhibitory Concentration 50 ; Janus Kinase 2 - chemistry ; Kinetics ; Medical sciences ; Models, Chemical ; Models, Molecular ; Molecular Conformation ; Monte Carlo Method ; Pharmacology. Drug treatments ; Piperidines ; Protein Binding ; Protein Kinase Inhibitors - chemical synthesis ; Protein Kinase Inhibitors - pharmacology ; Pyrimidines - chemical synthesis ; Pyrimidines - pharmacology ; Pyrroles - chemical synthesis ; Pyrroles - pharmacology ; Stereoisomerism</subject><ispartof>Journal of medicinal chemistry, 2008-12, Vol.51 (24), p.8012-8018</ispartof><rights>Copyright © 2008 U.S. Government</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a537t-31b5970c24059b3a967bb6ec396c48cd914bfb1553ac95c5f1ae3afacfbd3aac3</citedby><cites>FETCH-LOGICAL-a537t-31b5970c24059b3a967bb6ec396c48cd914bfb1553ac95c5f1ae3afacfbd3aac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20985244$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19053756$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jiang, Jian-kang</creatorcontrib><creatorcontrib>Ghoreschi, Kamran</creatorcontrib><creatorcontrib>Deflorian, Francesca</creatorcontrib><creatorcontrib>Chen, Zhi</creatorcontrib><creatorcontrib>Perreira, Melissa</creatorcontrib><creatorcontrib>Pesu, Marko</creatorcontrib><creatorcontrib>Smith, Jeremy</creatorcontrib><creatorcontrib>Nguyen, Dac-Trung</creatorcontrib><creatorcontrib>Liu, Eric H</creatorcontrib><creatorcontrib>Leister, William</creatorcontrib><creatorcontrib>Costanzi, Stefano</creatorcontrib><creatorcontrib>O’Shea, John J</creatorcontrib><creatorcontrib>Thomas, Craig J</creatorcontrib><title>Examining the Chirality, Conformation and Selective Kinase Inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Here, we examine the significance that stereochemistry plays within the clinically relevant Janus kinase 3 (Jak3) inhibitor 1 (CP-690,550). A synthesis of all four enantiopure stereoisomers of the drug was carried out and an examination of each compound revealed that only the enantiopure 3R,4R isomer was capable of blocking Stat5 phosphorylation (Jak3 dependent). Each compound was profiled across a panel of over 350 kinases, which revealed a high level of selectivity for the Jak family kinases for these related compounds. Each stereoisomer retained a degree of binding to Jak3 and Jak2 and the 3R,4S and 3S,4R stereoisomers were further revealed to have binding affinity for selected members of the STE7 and STE20 subfamily of kinases. Finally, an appraisal of the minimum energy conformation of each stereoisomer and molecular docking at Jak3 was performed in an effort to better understand each compounds selectivity and potency profiles.</description><subject>Biological and medical sciences</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>Drug Design</subject><subject>Humans</subject><subject>Hydrogen Bonding</subject><subject>Immunomodulators</subject><subject>Inhibitory Concentration 50</subject><subject>Janus Kinase 2 - chemistry</subject><subject>Kinetics</subject><subject>Medical sciences</subject><subject>Models, Chemical</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Monte Carlo Method</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperidines</subject><subject>Protein Binding</subject><subject>Protein Kinase Inhibitors - chemical synthesis</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Pyrimidines - chemical synthesis</subject><subject>Pyrimidines - pharmacology</subject><subject>Pyrroles - chemical synthesis</subject><subject>Pyrroles - pharmacology</subject><subject>Stereoisomerism</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNptkc1u1DAQxyMEokvhwAugXJA20hr8mWwulVBUaEUr2m05IWRNHKfxktiRk1abh-Pd8HZXW5CQD_bM_Obv-YiitwR_IJiSj-tuiQnhtHwWzYigGPEl5s-jGcaUIppSdhS9GoY1xpgRyl5GRyTHgmUinUW_TzfQGWvsXTw2Oi4a46E147SIC2dr5zsYjbMx2Cq-0a1Wo3nQ8VdjYdDxuW1MaR7jro4Zms_ZasFXCeKo02MztSj4dq95dob6yXvXuh90wVD1M1imM5WxgZ7aZFuES3rTa__oJFtnyHcb13vXg9XWjN60Op4XVyjN8UIInLyOXtTQDvrN_j6Ovn8-vS3O0MW3L-fFpwsEoc0RMVKKPMOKcizykkGeZmWZasXyVPGlqnLCy7okQjBQuVCiJqAZ1KDqsmIAih1HJzvd_r7sdKW0HcOYZB9aAD9JB0b-G7GmkXfuQdI0xeEEgWQnoLwbBq_rQy7BcrtDedhhYN_9_dkTuV9aAN7vARgUtLUHq8xw4CjOl4JyHji048ww6s0hDv6XTLOgJG-vbuRKXF4X_PJaZk-6oAa5dvfehpn-p8A_qYnAKg</recordid><startdate>20081225</startdate><enddate>20081225</enddate><creator>Jiang, Jian-kang</creator><creator>Ghoreschi, Kamran</creator><creator>Deflorian, Francesca</creator><creator>Chen, Zhi</creator><creator>Perreira, Melissa</creator><creator>Pesu, Marko</creator><creator>Smith, Jeremy</creator><creator>Nguyen, Dac-Trung</creator><creator>Liu, Eric H</creator><creator>Leister, William</creator><creator>Costanzi, Stefano</creator><creator>O’Shea, John J</creator><creator>Thomas, Craig J</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20081225</creationdate><title>Examining the Chirality, Conformation and Selective Kinase Inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)</title><author>Jiang, Jian-kang ; Ghoreschi, Kamran ; Deflorian, Francesca ; Chen, Zhi ; Perreira, Melissa ; Pesu, Marko ; Smith, Jeremy ; Nguyen, Dac-Trung ; Liu, Eric H ; Leister, William ; Costanzi, Stefano ; O’Shea, John J ; Thomas, Craig J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a537t-31b5970c24059b3a967bb6ec396c48cd914bfb1553ac95c5f1ae3afacfbd3aac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biological and medical sciences</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>Drug Design</topic><topic>Humans</topic><topic>Hydrogen Bonding</topic><topic>Immunomodulators</topic><topic>Inhibitory Concentration 50</topic><topic>Janus Kinase 2 - chemistry</topic><topic>Kinetics</topic><topic>Medical sciences</topic><topic>Models, Chemical</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Monte Carlo Method</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperidines</topic><topic>Protein Binding</topic><topic>Protein Kinase Inhibitors - chemical synthesis</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Pyrimidines - chemical synthesis</topic><topic>Pyrimidines - pharmacology</topic><topic>Pyrroles - chemical synthesis</topic><topic>Pyrroles - pharmacology</topic><topic>Stereoisomerism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jiang, Jian-kang</creatorcontrib><creatorcontrib>Ghoreschi, Kamran</creatorcontrib><creatorcontrib>Deflorian, Francesca</creatorcontrib><creatorcontrib>Chen, Zhi</creatorcontrib><creatorcontrib>Perreira, Melissa</creatorcontrib><creatorcontrib>Pesu, Marko</creatorcontrib><creatorcontrib>Smith, Jeremy</creatorcontrib><creatorcontrib>Nguyen, Dac-Trung</creatorcontrib><creatorcontrib>Liu, Eric H</creatorcontrib><creatorcontrib>Leister, William</creatorcontrib><creatorcontrib>Costanzi, Stefano</creatorcontrib><creatorcontrib>O’Shea, John J</creatorcontrib><creatorcontrib>Thomas, Craig J</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jiang, Jian-kang</au><au>Ghoreschi, Kamran</au><au>Deflorian, Francesca</au><au>Chen, Zhi</au><au>Perreira, Melissa</au><au>Pesu, Marko</au><au>Smith, Jeremy</au><au>Nguyen, Dac-Trung</au><au>Liu, Eric H</au><au>Leister, William</au><au>Costanzi, Stefano</au><au>O’Shea, John J</au><au>Thomas, Craig J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Examining the Chirality, Conformation and Selective Kinase Inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2008-12-25</date><risdate>2008</risdate><volume>51</volume><issue>24</issue><spage>8012</spage><epage>8018</epage><pages>8012-8018</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Here, we examine the significance that stereochemistry plays within the clinically relevant Janus kinase 3 (Jak3) inhibitor 1 (CP-690,550). A synthesis of all four enantiopure stereoisomers of the drug was carried out and an examination of each compound revealed that only the enantiopure 3R,4R isomer was capable of blocking Stat5 phosphorylation (Jak3 dependent). Each compound was profiled across a panel of over 350 kinases, which revealed a high level of selectivity for the Jak family kinases for these related compounds. Each stereoisomer retained a degree of binding to Jak3 and Jak2 and the 3R,4S and 3S,4R stereoisomers were further revealed to have binding affinity for selected members of the STE7 and STE20 subfamily of kinases. Finally, an appraisal of the minimum energy conformation of each stereoisomer and molecular docking at Jak3 was performed in an effort to better understand each compounds selectivity and potency profiles.</abstract><cop>Columbus, OH</cop><pub>American Chemical Society</pub><pmid>19053756</pmid><doi>10.1021/jm801142b</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2008-12, Vol.51 (24), p.8012-8018 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2660606 |
source | American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list) |
subjects | Biological and medical sciences Chemistry, Pharmaceutical - methods Drug Design Humans Hydrogen Bonding Immunomodulators Inhibitory Concentration 50 Janus Kinase 2 - chemistry Kinetics Medical sciences Models, Chemical Models, Molecular Molecular Conformation Monte Carlo Method Pharmacology. Drug treatments Piperidines Protein Binding Protein Kinase Inhibitors - chemical synthesis Protein Kinase Inhibitors - pharmacology Pyrimidines - chemical synthesis Pyrimidines - pharmacology Pyrroles - chemical synthesis Pyrroles - pharmacology Stereoisomerism |
title | Examining the Chirality, Conformation and Selective Kinase Inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T15%3A16%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Examining%20the%20Chirality,%20Conformation%20and%20Selective%20Kinase%20Inhibition%20of%203-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo%5B2,3-d%5Dpyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile%20(CP-690,550)&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Jiang,%20Jian-kang&rft.date=2008-12-25&rft.volume=51&rft.issue=24&rft.spage=8012&rft.epage=8018&rft.pages=8012-8018&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm801142b&rft_dat=%3Cacs_pubme%3Ef70934955%3C/acs_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a537t-31b5970c24059b3a967bb6ec396c48cd914bfb1553ac95c5f1ae3afacfbd3aac3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/19053756&rfr_iscdi=true |